|
|
Article: FDA announces renowned pediatric ethicist Robert M. Nelson, M.D., to join Office of Pediatric Therapeutics; Represents significant addition to agencys commitment to protect children enrolled in clinical trials.
- Article from:
- M2 Presswire
- Article date:
- September 15, 2006
CopyrightCOPYRIGHT 2006 Normans Media Ltd. This material is published under license from the publisher through the Gale Group, Farmington Hills, Michigan. All inquiries regarding rights should be directed to the Gale Group. (Hide copyright information)
|
M2 PRESSWIRE-15 September 2006-US FDA: FDA announces renowned pediatric ethicist Robert M. Nelson, M.D., to join Office of Pediatric Therapeutics; Represents significant addition to agencys commitment to protect children enrolled in clinical trials(C)1994-2006 M2 COMMUNICATIONS LTD
RDATE:14092006
The FDA today announced that on October 16, Robert M. Nelson, M.D., M.Div., Ph.D. will join FDA's Office of Pediatric Therapeutics and will be responsible for providing guidance and advice on ethical issues related to pediatric clinical trials and other pediatric issues involving any product regulated by FDA. Mandated by the Best Pharmaceuticals for Children ...
Related newspaper, magazine, and journal articles:
|
|
Article: FDA APPROVES RISPERDAL FOR TWO PSYCHIATRIC CONDITIONS IN ...
US Fed News Service, Including US State News;
August 22, 2007 ;
700+ words
... ... Dianne Murphy, M.D., director of FDA's Office of Pediatric Therapeutics. "These data have permitted the ... Titusville, N.J. For more information: FDA Office of Pediatric Therapeutics www.fda.gov/oc/opt/default.htm National ...
|
|